SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Ingredient guide · Ingredient reference

    NAD supplements: forms, dosing and evidence limits

    NAD-labelled supplements often supply precursors such as NR or NMN rather than NAD itself. Some raise blood biomarkers, but meaningful benefits remain inconsistent. There is no universally established dose, time of day or formulation for healthy aging, and injection is not a proven superior route.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    Start with the actual chemical form

    NR means nicotinamide riboside; NMN means nicotinamide mononucleotide. Niacin and nicotinamide are other related compounds. Their metabolism, evidence and adverse-effect profiles differ, so compare the named ingredient and amount rather than the large NAD wording on the front. [1][2]

    Study ranges are not recommended daily doses

    The 2026 NMN review included oral trials from 250 to 2,000 milligrams daily lasting 14 days to 24 weeks. These research exposures do not establish an optimal routine or long-term safety. More precursor did not reliably improve conventional metabolic outcomes. [3]

    Timing and delivery claims remain unsettled

    The human reviews do not establish a best morning, evening or fasting schedule across products and goals. Blood-marker changes also cannot rank all oral, sublingual or liposomal products by clinical benefit. Follow the actual product and clinical instructions rather than transferring a different formulation’s protocol. [1][4]

    Keep safety tied to dose and route

    High-dose niacin has recognized adverse effects, and short NMN tolerability findings cannot be applied to every blend. FDA has separately warned about compounded NAD+ injections. Imagine a clinic offers an infusion as a faster version of a capsule: faster delivery does not establish better outcomes or equivalent safety. [2][3][5]

    Hypothetical example — compare NAD-labelled products
    FeatureCheck
    NR or NMNExact compound
    Research doseNot universal guidance
    Timing claimClinical evidence for that schedule
    InjectionSeparate quality and safety questions
    NAD supplements: forms, dosing and evidence limits — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions - PMC
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    2. Niacin - Health Professional Fact Sheet
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    3. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis - PMC
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    4. NAD + precursor supplementation in human ageing: clinical evidence and challenges.
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    5. FDA reminds compounders to use ingredients suitable for sterile compounding | FDA
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.